Kotak Mahindra Bank will discontinue the Myntra Credit Card from 10 July 2025, migrating users to the League Platinum Card with updated benefits, exclusions, and reward terms.

Kotak Equity Hybrid Regular Growth - Growth: Get latest Kotak Equity Hybrid Regular Growth NAV, returns, analysis, performance. Visit now and invest in Kotak Equity Hybrid Regular Growth at Mint.

Macquarie, in its latest note, downgraded Kotak Mahindra Bank to ‘neutral’ but raised the target price to Rs 2,300.

Get latest NAV, Returns, SIP Returns, Performance, Ranks, Dividends, Portfolio, CRISIL Rank, Expert Recommendations, and Comparison with gold, stock,ULIP etc ...

Nestle Health Science bids to take control of Seres Therapeutics’ oral microbiome product Vowst for preventing C. diff infections.

Uday Kotak expressed concerns about the influence of money power in the stock market, emphasizing the need for capital formation and fair price discovery. He flagged the reliance on trading ...

Kotak emerging equity scheme direct growth detail page: Get detailed insights of Kotak emerging equity scheme direct growth detail page with current NAV, rating, fund return, performance, category ...

Kotak Ace - Frontline Equity Fund: Get the Latest NAV Value, Performance and Returns of Kotak Ace - Frontline Equity Fund. Kotak Mahindra Life Insurance India Insurance ULIP Plans ...

President Trump last week touted a $550 billion investment in the US that Japan made as part of trade negotiations "to lower their tariffs a little bit," as he described it. On Saturday, Japanese ...

A comprehensive analysis of the best sports betting apps in 2025, featuring in-depth reviews of leading sportsbooks such as FanDuel, DraftKings and Caesars ...